ES2170239T3 - Peptidos antifungicos de d-aminoacidos basados en histatina. - Google Patents

Peptidos antifungicos de d-aminoacidos basados en histatina.

Info

Publication number
ES2170239T3
ES2170239T3 ES96919334T ES96919334T ES2170239T3 ES 2170239 T3 ES2170239 T3 ES 2170239T3 ES 96919334 T ES96919334 T ES 96919334T ES 96919334 T ES96919334 T ES 96919334T ES 2170239 T3 ES2170239 T3 ES 2170239T3
Authority
ES
Spain
Prior art keywords
histatin
peptides
antifungic
amino acids
histatins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES96919334T
Other languages
English (en)
Inventor
Frank G Oppenheim
Tao Xu
Peter Spacciapoli
F Donald Roberts
Phillip M Friden
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Boston University
Demegen Inc
Original Assignee
Boston University
Demegen Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boston University, Demegen Inc filed Critical Boston University
Application granted granted Critical
Publication of ES2170239T3 publication Critical patent/ES2170239T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4723—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE DESCRIBEN HISTATINAS DE D ADOS EN HISTATINA Y METODOS PARA EL TRATAMIENTO DE INFECCIONES FUNGICAS O BACTERIANAS. ESTAS HISTATINAS DE D PEPTIDOS BASADOS EN HISTATINAS SON AGENTES ANTIFUNGICOS O ANTIBACTERIANOS DE DURACION MAS PROLONGADA QUE SUS ANALOGOS L ENANTIOMERICOS.
ES96919334T 1995-06-07 1996-06-07 Peptidos antifungicos de d-aminoacidos basados en histatina. Expired - Lifetime ES2170239T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/485,273 US5646119A (en) 1991-11-01 1995-06-07 D-amino acid histatin-based peptides as anti-fungal and anti-bacterial agents

Publications (1)

Publication Number Publication Date
ES2170239T3 true ES2170239T3 (es) 2002-08-01

Family

ID=23927535

Family Applications (1)

Application Number Title Priority Date Filing Date
ES96919334T Expired - Lifetime ES2170239T3 (es) 1995-06-07 1996-06-07 Peptidos antifungicos de d-aminoacidos basados en histatina.

Country Status (10)

Country Link
US (1) US5646119A (es)
EP (1) EP0832120B1 (es)
JP (1) JPH11507376A (es)
AT (1) ATE213500T1 (es)
AU (1) AU711526B2 (es)
CA (1) CA2221780A1 (es)
DE (1) DE69619369T2 (es)
ES (1) ES2170239T3 (es)
IL (1) IL122387A0 (es)
WO (1) WO1996040770A2 (es)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5885965A (en) * 1991-11-01 1999-03-23 Periodontix, Inc. Anti-fungal D-amino acid histatin-based peptides
US5912230A (en) * 1991-11-01 1999-06-15 Periodontix, Inc. Anti-fungal and anti-bacterial histatin-based peptides
US6531573B1 (en) * 1997-12-18 2003-03-11 Trustees Of Boston University Antifungal and antibacterial peptides
US8283315B2 (en) 1998-08-28 2012-10-09 Lytix Biopharma As Inhibition of tumour growth
GB9818938D0 (en) 1998-08-28 1998-10-21 Alpharma As Bioactive peptides
US6528488B2 (en) * 1999-01-08 2003-03-04 Demegen, Inc. Method for treating cystic fibrosis
RU2147234C1 (ru) * 1999-03-09 2000-04-10 Жемчугов Владислав Евгеньевич Препарат для профилактики и лечения особо опасных инфекционных заболеваний
US20030143234A1 (en) * 1999-08-20 2003-07-31 Wenyuan Shi Anti-microbial targeting chimeric pharmaceutical
US7569542B2 (en) 1999-08-20 2009-08-04 The Regents Of The University Of California Anti-microbial targeting chimeric pharmaceutical
US20050164248A1 (en) * 1999-08-23 2005-07-28 Matthew Glenn Compositions isolated from bovine tissues and methods for their use
US6833435B2 (en) 1999-08-23 2004-12-21 Matthew Glenn Compositions isolated from bovine tissues and methods for their use
CA2285673C (en) 1999-10-21 2008-07-29 Gilles Andre Lajoie Cyclic analogs of histatins
US7199102B2 (en) 2000-08-24 2007-04-03 The Regents Of The University Of California Orally administered peptides synergize statin activity
US6664230B1 (en) * 2000-08-24 2003-12-16 The Regents Of The University Of California Orally administered peptides to ameliorate atherosclerosis
US6726898B2 (en) 2000-11-17 2004-04-27 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US6576226B1 (en) * 2000-11-17 2003-06-10 Gary R. Jernberg Local delivery of agents for disruption and inhibition of bacterial biofilm for treatment of periodontal disease
US7090497B1 (en) 2001-02-21 2006-08-15 Harris David M Method of periodontal laser treatment
US20040127892A1 (en) * 2002-01-31 2004-07-01 Harris David M. Periodontal laser and methods
US7033769B2 (en) 2002-05-23 2006-04-25 The United States Of America As Represented By The Secretary Of The Army Method for discovering one or more peptides adapted for specific binding to a microorganism of interest
US7087228B2 (en) * 2002-07-03 2006-08-08 University Of Southern California Preventing tooth decay and infective endocarditis using natural oligopeptides
US7736857B2 (en) * 2003-04-01 2010-06-15 Proactive Oral Solutions, Inc. Caries risk test for predicting and assessing the risk of disease
US7875598B2 (en) * 2004-03-04 2011-01-25 The Regents Of The University Of California Compositions useful for the treatment of microbial infections
KR20070089996A (ko) 2004-12-06 2007-09-04 더 리전트 오브 더 유니버시티 오브 캘리포니아 세동맥의 구조 및 기능의 개선 방법
US9127045B2 (en) * 2005-11-17 2015-09-08 University Of Southern California Method of inhibiting bacterial growth and biofilm formation with natural quorum sensing peptides
CA2957056A1 (en) * 2006-09-06 2008-03-13 C3 Jian, Inc. Selectively targeted antimicrobial peptides and the use thereof
US20130288964A1 (en) 2008-01-07 2013-10-31 Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Pa Use of peptides for promoting wound healing
MX2010007442A (es) * 2008-01-07 2010-12-21 Vereniging Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patientenzorg Uso de peptidos para promover la curacion de heridas.
US20100047734A1 (en) * 2008-08-20 2010-02-25 PathoLase, Inc. Periodontal laser treatment and laser applicator
EP2536379A2 (en) * 2010-02-19 2012-12-26 The University Of South Dakota Rechargeable long-term antifungal denture materials
TWI489991B (zh) * 2011-10-26 2015-07-01 Nat Univ Tsing Hua 具高鹽類耐受性之抗微生物胜肽及其製造方法
US20130310327A1 (en) 2012-05-18 2013-11-21 Rapid Pathogen Screening, Inc. Histatin for Corneal Wound Healing and Ocular Surface Disease
US9556226B2 (en) 2013-03-15 2017-01-31 The Board Of Trustees Of The University Of Arkansas Peptides with antifungal activity and methods of using the peptides
WO2016015691A1 (en) 2014-07-30 2016-02-04 Albert SARKESSYAN A pharmaceutical composition having antibacterial and virucidal effects
US9856302B2 (en) * 2015-07-23 2018-01-02 General Biologicals Corporation Anti-microbial peptide and method for treating microbial infection
US20170022256A1 (en) * 2015-07-23 2017-01-26 General Biologicals Corporation Anti-fungal and anti-bacterial peptide and therapeutic method using same
US20250276038A1 (en) * 2021-07-23 2025-09-04 Visus Therapeutics, Inc. Histatin combinations and methods for treating or inhibiting cell loss

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4725576A (en) * 1983-12-29 1988-02-16 Research Foundation Of State University Of New York Fungicidal polypeptide compositions containing L-histidine and methods for use therefore
US5032574A (en) * 1988-05-26 1991-07-16 Invitron Corporation Novel antimicrobial peptide
US5221732A (en) * 1988-12-06 1993-06-22 The United States Of America As Represented By The Department Of Health And Human Services Antimicrobial magainin modified peptides
US5459237A (en) * 1990-02-08 1995-10-17 Magainin Pharmaceuticals Inc. Peptide compositions and uses therefor
NZ237202A (en) * 1990-02-23 1994-01-26 Bristol Myers Squibb Co Composition containing beta-lactam antibiotic and cationic oligopeptide
US5447914A (en) * 1990-06-21 1995-09-05 Emory University Antimicrobial peptides
JP2818056B2 (ja) * 1990-09-07 1998-10-30 森永乳業株式会社 抗菌性ペプチドおよび抗菌剤
JP3523252B2 (ja) * 1990-11-21 2004-04-26 ホウテン ファーマシューティカルズ インコーポレイテッド 等モル多種オリゴマー混合物、特にオリゴペプチド混合物の合成
AU648140B2 (en) * 1991-02-01 1994-04-14 Virtual Drug Development, Inc. Reverse antimicrobial peptides and antimicrobial compositions
US5225399A (en) * 1991-04-15 1993-07-06 The Children's Hospital Of Philadelphia Antimicrobial amphiphilic peptides
US5239059A (en) * 1991-05-10 1993-08-24 The Children's Hospital Of Philadelphia Ion-channel forming peptides
US5547939A (en) * 1991-06-14 1996-08-20 The Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
US5324716A (en) * 1991-06-14 1994-06-28 Regents Of The University Of California Broad spectrum antimicrobial compounds and methods of use
EP0667871A1 (en) * 1991-09-13 1995-08-23 Magainin Pharmaceuticals Inc. Biologically active amphiphilic peptide compositions and uses therefor
US5486503A (en) * 1991-11-01 1996-01-23 The Trustees Of Boston University Anti-fungal histatin-based peptides
US5424290A (en) * 1992-10-26 1995-06-13 Magainin Pharmaceuticals Inc. Biologically active peptides and uses therefor
JPH06234653A (ja) * 1993-02-10 1994-08-23 Sunstar Inc 歯周組織再生促進剤および材料
US5459235A (en) * 1993-03-19 1995-10-17 The Regents Of The University Of California Antimicrobial peptides antibodies and nucleic acid molecules from bovine neutrophils
JPH06287146A (ja) * 1993-03-31 1994-10-11 Sunstar Inc 皮膚外用剤
US5549894A (en) * 1994-01-18 1996-08-27 Allergan, Inc. Disinfecton formulations and methods using D-enantiomeric anti-microbial peptides

Also Published As

Publication number Publication date
AU6169696A (en) 1996-12-30
AU711526B2 (en) 1999-10-14
DE69619369T2 (de) 2002-08-14
IL122387A0 (en) 1998-06-15
DE69619369D1 (de) 2002-03-28
CA2221780A1 (en) 1996-12-19
JPH11507376A (ja) 1999-06-29
ATE213500T1 (de) 2002-03-15
US5646119A (en) 1997-07-08
WO1996040770A3 (en) 1997-02-06
EP0832120A2 (en) 1998-04-01
EP0832120B1 (en) 2002-02-20
WO1996040770A2 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
ES2170239T3 (es) Peptidos antifungicos de d-aminoacidos basados en histatina.
IL122386A0 (en) Anti-fungal and anti-bacterial histatin-based peptides
DE69835279D1 (de) Zusammensetzungen und verfahren zur behandlung von infektionen unter verwendung von kationischen peptiden allein oder in kombination mit antibiotika
RU95106823A (ru) Сукциноиламиногидроксиэтиламиносульфонамиды, фармацевтическая композиция, способ ингибирования ретровирусной протеазы, способ лечения ретровирусной инфекции способ лечения спида
ATE218579T1 (de) Zusammensetzungen und methoden zur behandlung von infektionen unter verwendung von indolicidin- analogen
DE69526216D1 (de) Antifungaleverfahren und mitteln
DE69703689D1 (de) Therapeutische anwendungen von bpi-protein-produkten zur behandlung von humaner meningococcämia
DE69401577D1 (de) Verabreichung von lamotrigin zur behandlung von neuro-aids
ATE280777T1 (de) Bradykinin-antagonist peptide mit n- substituierten glycinen
DE69530844D1 (de) Verfahren und substanzen gegen protozoen
DE69631381T2 (de) Therapeutische und diagnostische agenzien zur behandlung mikrobieller infektionen
DE69914911D1 (de) Pharmazeutische präparate zur bekämpfung oder prophylaxe von mikroorganismen infizierten oberflächen
ATE376557T1 (de) Antimikrobielle sulfonamide-derivate von lipopeptidantibiotika
ATE373091T1 (de) Verfahren zur gewinnung und anwendung neuer humaner defensine als biologisch aktive eiweisstoffe zur behandlung von infektionen und anderen erkrankungen
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
DE69413637D1 (de) Verwendung von verzweigtkettigen Aminosäuren zur Herstellung eines Arzneimittels zur Behandlung von tardiver Dyskinesia
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE69514928D1 (de) Gegen protozoen wirksamezyklische tetrapeptide
DE60011601D1 (de) Rekombinantes sp-a zur behandlung und vorbeugung von pulmonaren infektionen und entzündungen
DE69906701D1 (de) Topische verwendung von loperamid zur behandlung mikrobieller infektionen
DE69231465D1 (de) Methode und zusammensetzung zur behandlung von herpes ähnlichen krankheiten
EP0974360A3 (en) Pharmaceutical preparations for use in combatting or preventing surface infections caused by microorganisms
MX9605312A (es) Dipsipeptidos ciclicos antifungales.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 832120

Country of ref document: ES